Medicine and Dentistry
Uveitis
100%
Human Immunodeficiency Virus
65%
Visual Acuity
34%
Disease
24%
Hazard Ratio
23%
Iridocyclitis
21%
Cytomegalovirus Retinitis
21%
Visual Impairment
20%
Macular Edema
18%
Antiretroviral Therapy
17%
Immunosuppressive Treatment
16%
Cataract Surgery
15%
Juvenile Idiopathic Arthritis
15%
Highly Active Antiretroviral Therapy
15%
Immunosuppressive Drug
15%
Eye Inflammation
14%
Cicatricial Pemphigoid
14%
Ophthalmology
14%
Retinitis
13%
Retina Macula Cystoid Edema
12%
Malignant Neoplasm
12%
Drug Therapy
12%
Prevalence
11%
Cataract
11%
Cohort Analysis
11%
Inflammatory Disorder
10%
Eye Disease
10%
Optical Coherence Tomography
10%
Systemic Therapy
10%
Fluocinolone Acetonide
10%
Chorioretinitis
9%
Odds Ratio
8%
Human Immunodeficiency Virus Infection
8%
Predictive Factor
8%
Best Corrected Visual Acuity
8%
Retrospective Cohort Study
8%
Intermediate Uveitis
8%
Intraocular Pressure
8%
Steroid Treatment
8%
Scleritis
8%
Choroiditis
8%
Implant
7%
Quality of Life
7%
Cancer Risk
7%
Visual Field
6%
Acute Retinal Necrosis
6%
Triamcinolone Acetonide
6%
Vitreous
5%
Dexamethasone
5%
Corticosteroid Therapy
5%
Keyphrases
Uveitis
49%
Confidence Interval
35%
United States
31%
AIDS/HIV
31%
Ocular Inflammation
24%
North America
23%
People Living with HIV (PLHIV)
22%
Antiretroviral Therapy
21%
Visual Acuity
18%
Canada
18%
Panuveitis
18%
Risk Factors
17%
Non-infectious
16%
CD4 Count
15%
Ocular Complications
14%
Non-infectious Uveitis
14%
Inflammatory Eye Disease
14%
Cataract Surgery
13%
Anterior Uveitis
12%
Intermediate Uveitis
11%
Hazard Ratio
11%
Cystoid Macular Edema
11%
Cytomegalovirus Retinitis
10%
Remission
10%
Highly Active Antiretroviral Therapy (HAART)
10%
Immunosuppression
10%
Inflammation
10%
Cataract
9%
Birdshot Chorioretinitis
9%
Systemic Juvenile Idiopathic Arthritis (sJIA)
9%
Juvenile Idiopathic Arthritis-associated Uveitis
9%
Vision Loss
8%
Adjusted Hazard Ratio
8%
Corticosteroids
8%
Mucous Membrane Pemphigoid
8%
Best-corrected Visual Acuity
8%
Ocular mucous Membrane Pemphigoid
7%
HIV Patients
7%
Posterior Uveitis
7%
Immunosuppressive Therapy
7%
Retrospective Cohort Study
7%
Odds Ratio
7%
Adalimumab
7%
Corticosteroid-sparing
7%
Topical Corticosteroids
7%
Uveitic
7%
AIDS-defining Illness
6%
Incidence Rate
6%
Scleritis
6%
Viral Suppression
6%
Pharmacology, Toxicology and Pharmaceutical Science
Uveitis
54%
HIV
51%
Inflammation
18%
Eye Inflammation
18%
Immunosuppressive Agent
14%
Inflammatory Disease
14%
Remission
12%
Cohort Study
12%
Disease
11%
Cataract
11%
Prevalence
11%
Juvenile Rheumatoid Arthritis
10%
Macular Edema
10%
Visual Impairment
9%
Mycophenolic Acid
8%
Adalimumab
8%
Malignant Neoplasm
8%
Side Effect
8%
Iridocyclitis
7%
Methotrexate
7%
Eye Disease
7%
Prednisone
7%
Intermediate Uveitis
6%
Adverse Event
6%
Retina Macula Cystoid Edema
6%
Dexamethasone
6%
Pharmacotherapy
6%
Mucous Membrane Pemphigoid
5%
Non-Steroidal Anti-Inflammatory Drug
5%
Triamcinolone Acetonide
5%
Implant
5%
Chronic Kidney Failure
5%